Radiation Therapy: Intensity-Modulated Market Assessment

A Panel Discussion Among Ten Radiation Oncologists.

August 2007

Study Description and Objectives

§    Understand current use of IMRT and stereotactic radiosurgery.

§    Identify the major players and most important attributes involved in decisions regarding the purchase of equipment for IMRT and stereotactic radiosurgery.

§    Determine the barriers and facilitators to using IMRT and stereotactic radiosurgery, and how companies can better serve these markets with products and/or services.

§    Estimate trends in use and market dynamics over the next 1-3 years.

§    Compare Cyberknife (Accuray – stereotactic radiosurgery) to Hi Art (TomoTherapy - IMRT).

o        Impact of reimbursement differences

o        Perception of market positioning

o        Interchangeability of these two products

Companies and Products Mentioned in This Report

Inclusion Criteria

 Hospitals Represented

§    New Jersey Medical School – University Hospital Cancer Center, NJ

§    University of Pennsylvania, PA

§    Temple University Hospital, PA

§    Ironwood Cancer and Research Center, AZ

§    St. Joseph’s Wayne Hospital, NJ

§    Mercy Hospital, FL

§    University of California San Francisco, CA

§    Dana-Farber Cancer Institute/Brigham & Women's Hospital, MA

§    Texas Cancer Clinic, TX

§    Community Cancer Center, FL

Reports become free one year after the publication date.